Literature DB >> 23747999

Pharmaceutical salts: a summary on doses of salt formers from the Orange Book.

C Saal1, A Becker.   

Abstract

Over half of the active pharmaceutical ingredients currently approved within the US are pharmaceutical salts. Selection of suitable pharmaceutical salts is carried out during late research or early development phase. Therefore several properties of different pharmaceutical salts of a new chemical entity are assessed during salt screening and salt selection. This typically includes physico-chemical behavior, dissolution rate and pharmacokinetics of a pharmaceutical salt. Beyond these properties also toxicological aspects have to be taken into account. As a starting point for a toxicological assessment we present an overview of the usage of pharmaceutical salts as described in the FDA's Orange Book including maximum daily doses for the most important administration routes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Counter ions; Drug development; Pharmaceutical salts; Salt screening; Salt selection; Toxicology

Mesh:

Substances:

Year:  2013        PMID: 23747999     DOI: 10.1016/j.ejps.2013.05.026

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology.

Authors:  Mustafa Bookwala; Priyanka Thipsay; Samir Ross; Feng Zhang; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2018-08-04       Impact factor: 5.571

2.  The crystal structures of two novel polymorphs of bis-(oxonium) ethane-1,2-di-sulfonate.

Authors:  Jaroslaw Mazurek; Ana Fernandez-Casares
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-10-03

3.  Combining Co-Amorphous-Based Spray Drying with Inert Carriers to Achieve Improved Bioavailability and Excellent Downstream Manufacturability.

Authors:  Yingxi Zhang; Yuan Gao; Xiaoxiao Du; Rou Guan; Zhonggui He; Hongzhuo Liu
Journal:  Pharmaceutics       Date:  2020-11-08       Impact factor: 6.321

4.  BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2.

Authors:  Yogesh Sutar; Tejabhiram Yadavalli; Sagar Kumar Paul; Sudipta Mallick; Raghuram Koganti; Harsh Chauhan; Abhijit A Date; Deepak Shukla
Journal:  Pharmaceutics       Date:  2021-11-12       Impact factor: 6.321

Review 5.  Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts.

Authors:  Sonali S Bharate
Journal:  Pharm Res       Date:  2021-07-23       Impact factor: 4.200

6.  Solubility Improvement of Benexate through Salt Formation Using Artificial Sweetener.

Authors:  Okky Dwichandra Putra; Daiki Umeda; Eriko Fujita; Tamami Haraguchi; Takahiro Uchida; Etsuo Yonemochi; Hidehiro Uekusa
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

Review 7.  Discovery, Development, Inventions, and Patent Trends on Mobocertinib Succinate: The First-in-Class Oral Treatment for NSCLC with EGFR Exon 20 Insertions.

Authors:  Mohd Imran; Shah Alam Khan; Mohammed Kanan Alshammari; Meshal Ayedh Alreshidi; Abeer Abdullah Alreshidi; Rawan Sulaiman Alghonaim; Fayez Aboud Alanazi; Sultan Alshehri; Mohammed M Ghoneim; Faiyaz Shakeel
Journal:  Biomedicines       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.